Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

First generic warfarin product cleared by the FDA

April 1, 1997

Genzyme Transgenics receives further funding for development of transgenic ATIII

April 1, 1997

Terumo claims platelet aggregation/thromboxane synthase inhibitors

April 1, 1997

Antiplatelet 5-HT2A receptor antagonist characterized by Toa Eiyo

March 27, 1997

Novel orally active antithrombotic agent from Fuji Yakuhin

March 27, 1997

Biological role of CD39 uncovered by Immunex and collaborators

March 26, 1997

Biogen licenses Hirulog

March 26, 1997

Cor Therapeutics receives nonapprovable letter for Integrilin NDA

March 26, 1997

CPMP approves lepirudin

March 24, 1997

RPR seeks FDA approval for new indications for Lovenox

March 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...